Originator Users in Finland Hesitant on Using Biosimilars
Nearly half (47%) of biosimilar users knew they were using biosimilars but 31% thought the medicine was an originator. In contrast, 80% of originator users knew they were using an originator, and none thought they were using a biosimilar.
Linkedin Mari European Medicines Agency Oriola Corporation Expert Services Medicine Act Reference Product
Source: hcplive.com